Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects
Clinical trial NCT05110118 · COMPLETED
Trial details
- NCT number
- NCT05110118
- Sponsor
- Shandong Boan Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2021-01-13
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.